BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs2476601
,
PTEN
,
Fatty acid metabolic process
,
Breast Cancer
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hmg 17
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Triceps muscles from 3mo old mice with conditional PRX1-Cre-NF1 knockout
TCF7 knockdown in a multipotential hematopoietic cell line
Norovirus replication in Huh-7 cells
Thymic tumors in TCF1 knockout and heterozygous mice
Lung expression profiling in irradiated mice treated with (S)-FTY-phosphonate, SEW-2871, and FTY-720
Explore Curated Studies Results
Literature
Most Relevant Literature
HMGN2 regulates non-tuberculous mycobacteria survival via modulation of M1 macrophage polarization.
HMGN2 protein inhibits the growth of infected T24 cells in vitro.
Spatial and Temporal Expression of High-Mobility-Group Nucleosome-Binding (HMGN) Genes in Brain Area…
Recombinant jurkat cells (HMGN2-T cells) secrete cytokines and inhibit the growth of tumor cells.
The miR-144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia
Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine…
Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values
Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP
Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated W…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ